Ex-Dividend Stocks: A total of 17 stocks, including LIC, IndusInd Bank, Supreme Industries, Dr Lal PathLabs and CARE Ratings, ...

Earnings call Dr. Lal PathLabs reported 10.7% YoY revenue growth and 19.3% PAT growth in Q3 FY25, despite no price increases. The company is executing a multi-pronged strategy of geographic expansion, ...

Care Ratings expects Dr Lal PathLabs' revenue to grow by 11-12 per cent per annum in the near-to-medium term driven by ...

Small-cap mutual funds ramped up exposure to industrial products and pharmaceutical stocks in May 2026, with Vijaya ...

Dr. Lal Path Labs hits a 52-week high driven by Dubai expansion, strong FY27 growth guidance, solid earnings performance, and ...

Discover Dr Lal Path Labs diagnostic services in New Delhi, Delhi. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information on ...

Bengaluru: Dr. Lal Path Labs reported a ‍lower third-quarter profit on Friday after taking a one-time charge ⁠linked to India's new labour code, despite strong demand for its bundled test packages.

Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

Bengaluru: Dr Lal Path Labs, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid ...

Discover Dr Lal Path Labs diagnostic services in Indore, Madhya Pradesh. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information ...

Earnings call Dr. Lal PathLabs reported FY25 revenue of ₹2,461 crore, up 10.5% YoY, with PAT rising 35.9% to ₹492 crore (including a one-time tax benefit). Q4 margins expanded, but FY26 guidance ...